Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
Part of paid clinical trials in San Diego, California.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT05241990
- Status
- Recruiting
Conditions
- Alcohol Use, Unspecified
- Hiv
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Practice Facilitation — BEHAVIORALA practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use.
- Alcohol Stepped Care — BEHAVIORALBased on severity of alcohol use, individuals receive brief alcohol intervention delivered in person or by computer, cognitive behavioral therapy by person or computer, or pharmacotherapy for alcohol use disorder
Study Details
Despite availability of evidence-based alcohol reduction interventions (EBI), unhealthy alcohol use remains a barrier to HIV medication adherence, viral suppression and retention in HIV care and consequently HIV treatment as prevention (TASP). Guided by complementary implementation and evaluation frameworks-the Consolidated Framework for Implementation Research (CFIR) and RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance), The investigators will conduct a Hybrid Type 3 effectiveness-implementation evaluating implementation trial testing whether practice facilitation, an evidence-based multifaceted implementation strategy increases reach, adoption, implementation, and maintenance of stepped care for unhealthy alcohol use in three Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) HIV clinics located in Boston, San Diego, and Chapel Hill. The investigators will secondarily test whether practice facilitation is associated with decreased unhealthy alcohol use, and improved Antiretroviral Therapy (ART) adherence and viral suppression at the patient level. In practice facilitation, a practice coach will offer tools, resources, hands-on guidance, and content expertise to assist sites in offering a stepped care model of alcohol treatment to patients with unhealthy alcohol use. Stepped care will include brief intervention, cognitive behavioral therapy, and alcohol pharmacotherapy. The practice facilitation intervention will be rolled out sequentially across sites. There will be three phases at each site: pre-implementation planning, implementation with formative evaluation, and post-implementation summative evaluation. Using mixed methods, The investigators specifically propose to meet the following specific aims: (Aim 1) Tailor the practice facilitation intervention to each site using mixed methods (pre-implementation); (Aim 2a) Determine the effects of practice facilitation on implementation of stepped care (primary) and alcohol use and HIV-related outcomes (secondary) using interrupted time series analysis with synthetic controls (summative evaluation); (Aim 2b) Determine the effect of practice facilitation on reach, adoption, and maintenance of evidence-based alcohol treatment using mixed methods (formative evaluation); and (Aim 3) Describe barriers and facilitators to implementation of alcohol-related interventions at each site to describe maintenance and inform widespread sustainable implementation.
Key Dates
- Start date
- Feb 15, 2023
- Status verified
- Jul 2025
- Primary completion
- Jun 15, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Alcohol Stepped CareBased on severity of alcohol use, individuals receive brief alcohol intervention delivered in person or by computer, cognitive behavioral therapy by person or computer, or pharmacotherapy for alcohol use disorder
Primary Outcome Measure
Implementation as assessed by the percent of patients receiving an alcohol intervention [ Time Frame: 12 months ]
Central Contacts
- JoAnna Mathena410-955-9534
- Geetanjali Chander14432872030
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Diego | San Diego | California | 92103 | Edward C Cachay 6195433995 |
| Fenway Community Health | Boston | Massachusetts | 02114 | Conall O'Cleirigh 617-643-0385 |
| University of North Carolina | Chapel Hill | North Carolina | 27599-7215 |
Find similar trials in San Diego, CA
Related Studies
- The Use of Leukapheresis to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- The Use of Lymph Node Biopsies to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Collection of Blood for Multiple Collaborative StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal InjuryRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina